Inactivation of Msx1 and Msx2 in neural crest reveals an unexpected role in suppressing heterotopic bone formation in the head.
In an effort to understand the morphogenetic forces that shape the bones of the skull, we inactivated Msx1 and Msx2 conditionally in neural crest. We show that Wnt1-Cre inactivation of up to three Msx1/2 alleles results in a progressively larger defect in the neural crest-derived frontal bone. Unexpectedly, in embryos lacking all four Msx1/2 alleles, the large defect is filled in with mispatterned bone consisting of ectopic islands of bone between the reduced frontal bones, just anterior to the parietal bones. The bone is derived from neural crest, not mesoderm, and, from DiI cell marking experiments, originates in a normally non-osteogenic layer of cells through which the rudiment elongates apically. Associated with the heterotopic osteogenesis is an upregulation of Bmp signaling in this cell layer. Prevention of this upregulation by implantation of noggin-soaked beads in head explants also prevented heterotopic bone formation. These results suggest that Msx genes have a dual role in calvarial development: They are required for the differentiation and proliferation of osteogenic cells within rudiments, and they are also required to suppress an osteogenic program in a cell layer within which the rudiments grow. We suggest that the inactivation of this repressive activity may be one cause of Wormian bones, ectopic bones that are a feature of a variety of pathological conditions in which calvarial bone development is compromised.
Roybal
Paul G
PG
Department of Biochemistry and Molecular Biology, Norris Cancer Hospital, University of Southern California Keck School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA 90089-9176, USA.
Wu
Nancy L
NL
Sun
Jingjing
J
Ting
Man-chun
MC
Schafer
Christopher A
CA
Maxson
Robert E
RE
D000818:Animals; D019521:Body Patterning; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000378:metabolism; D002454:Cell Differentiation; D018398:Homeodomain Proteins / Q000235:genetics* / Q000378:metabolism; D051957:MSX1 Transcription Factor / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D009432:Neural Crest / Q000166:cytology* / Q000196:embryology / Q000378:metabolism; D010012:Osteogenesis / Q000235:genetics*; D012886:Skull / Q000196:embryology*
D019485:Bone Morphogenetic Proteins; D018398:Homeodomain Proteins; D051957:MSX1 Transcription Factor; C084119:MSX2 protein; C484084:Msx1 protein, mouse
Am J Med Genet A. 2007 Dec 15;143A(24):3243-51
18000970
Kokubyo Gakkai Zasshi. 2005 Mar;72(1):19-27
15856768
Development. 2004 Oct;131(20):5153-65
15459107
Nat Genet. 1997 Jan;15(1):42-6
8988167
J Bone Miner Res. 1995 Dec;10(12):1978-87
8619379
J Anat. 2005 Nov;207(5):637-53
16313397
Nat Genet. 1999 Jan;21(1):70-1
9916792
Development. 1999 Apr;126(8):1571-80
10079220
Ann Anat. 2002 Jan;184(1):1-7
11876477
Hum Mol Genet. 2006 Apr 15;15(8):1319-28
16540516
Development. 1998 Apr;125(7):1241-51
9477322
J Histochem Cytochem. 1992 Oct;40(10):1457-63
1527370
Histochem Cell Biol. 1999 Jun;111(6):435-43
10429965
Front Oral Biol. 2008;12:197-208
18391502
Dev Biol. 2007 Nov 15;311(2):335-46
17931618
Development. 1992 Oct;116(2):297-307
1283734
J Bone Miner Res. 2008 Mar;23(3):305-13
17967130
Curr Biol. 1998 Dec 3;8(24):1323-6
9843687
Development. 2003 Dec;130(24):6131-42
14597577
Development. 2000 Apr;127(8):1607-16
10725237
Mech Dev. 2007 Sep-Oct;124(9-10):729-45
17693062
Development. 2009 Mar;136(5):855-64
19201948
Mech Dev. 2008 Sep-Oct;125(9-10):797-808
18617001
Dev Dyn. 2006 Sep;235(9):2353-75
16680722
J Exp Zool. 1986 Aug;239(2):289-93
3746236
Genesis. 2007 Aug;45(8):477-81
17654563
Dev Biol. 2002 Jan 1;241(1):106-16
11784098